Delivery Order SPE2DB22D3010-SPE2DB25FP3LK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,021.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on August 25, 2025, with completion targeted for August 26, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $11,225.17 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on September 8, 2025, with a completion date of September 9, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injectors with a firm fixed price on August 29, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This delivery order was competitively awarded without a set-aside designation and is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $12,636.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on August 29, 2025, with a completion date of September 2, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $3,812.94 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on August 29, 2025, with a completion date of September 2, 2025. This firm fixed-price, non-set-aside delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, underscoring the company's role as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injectors with a ceiling value of $4,984.68. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order...
- The Defense Logistics Agency awarded a $6,184.55 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,863.77 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on August 11, 2025, with completion targeted for August 12, 2025. This delivery order utilizes firm fixed pricing with no set-aside designation, indicating the award was made through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the...
- The Defense Logistics Agency (DLA) awarded a $4,533.96 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pen injections on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,292.56 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of August 19, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under an open procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3LKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,377.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injections on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed price delivery order, which carries no set-aside designation, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion comprehensive pharmaceutical supply agreement running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a critical vendor in the federal medical procurement landscape, supplying a broad portfolio of pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's extensive contract history with the Defense Logistics Agency demonstrates its capability to meet federal procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order for Zepbound reflects AmerisourceBergen's role in supporting defense health operations through competitive, firm fixed price procurement arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 9/10/25 |